OPCH Option Care Health, Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.…
Industry Peers
Medical Care FacilitiesKey Statistics
About Option Care Health (NASDAQ: OPCH)
›
Option Care Health (NASDAQ: OPCH) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 6,528 employees.
The shares were at 31.61 USD on 19 November 2026, up 16.7% over 52 weeks. Its 52-week range is 18.01 USD to 36.80 USD: the price is 14.1% below the high and 75.5% above the low.
At a market capitalisation of 4.74B USD, it trades at 22.9 times trailing earnings and 15.2 times forward earnings. The median trailing P/E of its 18 largest Medical Care Facilities peers is 22.8, so OPCH is valued in line with them.
Option Care Health reports return on equity of 15.7%, an operating margin of 5.9% and revenue up 4.1% year over year.
Its debt exceeds its cash by 962.16M USD, a debt-to-equity ratio of 0.96. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 8 analysts cover the stock, with an average rating of Hold; their mean price target of 30.03 USD is 5.0% below the current price. The next earnings report is expected on 23 February 2027.